Alcover (sodium oxybate) / D&A Pharma, JUSTE group 
Welcome,         Profile    Billing    Logout  
 0 Diseases   0 Trials   0 Trials   58 News 
1 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Alcover (sodium oxybate) / D&A Pharma, JUSTE group
2019-001834-33: Efficacy and safety of Sodium Oxybate in reducing alcohol consumption and maintaining abstinence in alcohol-dependent subjects with high and very high drinking risk level. “OXYLIFE Study“ Efficacia e sicurezza del Sodio Oxibato nella riduzione del consumo alcolico e nel mantenimento dell’ astinenza in pazienti alcool dipendenti a rischio elevato/molto elevato di bere.

Not yet recruiting
3
240
Europe
ALCOVER, Oral solution, ALCOVER
LABORATORIO FARMACEUTICO CT SRL, LABORATORIO FARMACEUTICO CT SRL
Alcohol addiction DIPENDENZA DA ALCOL, Alcohol addiction DIPENDENZA DA ALCOL, Psychiatry and Psychology [F] - Behaviours [F01]
 
 

Download Options